Glaucoma, Macular Degeneration, and SSDI

The Social Security Administration (SSA) evaluates glaucoma and macular degeneration under separate visual criteria in Section 2.00 of the Blue Book, reflecting how each condition attacks vision differently. While glaucoma causes progressive peripheral visual field contraction evaluated primarily under Listing 2.03, macular degeneration damages central visual acuity evaluated under Listing 2.02.

Understanding the difference between these two evaluation pathways is essential for claimants suffering from severe vision loss. The SSA Listing of Impairments, found in 20 CFR Part 404, Subpart P, Appendix 1, requires distinct diagnostic tests and clinical measurements for each condition to determine whether an applicant qualifies for Social Security Disability Insurance (SSDI) at Step 3 of the sequential evaluation process.

Two Different Pathologies and Separate Blue Book Listings

Glaucoma and macular degeneration attack the visual system through entirely different anatomical mechanisms. Consequently, SSA does not apply a single general vision test to both conditions.

Glaucoma is characterized by elevated intraocular pressure or optic nerve neuropathy that gradually destroys retinal nerve fibers. This damage begins in the periphery, narrowing the claimant's field of view while often sparing central vision until advanced stages. Because an individual with advanced glaucoma may retain 20/20 central vision while navigating through a narrow visual tunnel, SSA evaluates the disease primarily under Blue Book Listing 2.03 for contraction of the visual field.

In contrast, age-related macular degeneration (AMD), whether in dry or wet form, attacks the macula at the center of the retina. The macula provides the high-resolution vision needed to read small text, identify faces, and perform detailed visual tasks. While peripheral vision usually remains functional, central vision deteriorates, creating dark spots or severe blurring. SSA therefore evaluates macular degeneration primarily under Blue Book Listing 2.02 for loss of central visual acuity.

Evaluating Glaucoma Under Blue Book Listing 2.03

To qualify for SSDI benefits under Listing 2.03, a claimant with glaucoma must demonstrate severe contraction of the visual field in their better eye. SSA evaluates the better eye because an individual with functional vision in one eye is not considered disabled under listing-level rules.

Under Listing 2.03, an applicant meets the listing by satisfying any of the following objective criteria in the better eye:

• Listing 2.03A: The widest diameter of the visual field subtends an angle no greater than 20 degrees around the point of fixation.
• Listing 2.03B: A mean deviation of 22 decibels or greater on automated static threshold perimetry, such as a Humphrey Field Analyzer using the 30-2 or 24-2 test pattern.
• Listing 2.03C: Visual field efficiency of twenty percent or less, determined by kinetic perimetry such as a Goldmann perimeter.

Section 2.00A(6) of the Blue Book establishes strict evidentiary requirements for perimetry testing. The testing must include documentation of compliance, fixation losses, false positive errors, and false negative errors. Automated static threshold perimetry is preferred by SSA because of its standardized calibration and reproducibility.

Evaluating Macular Degeneration Under Blue Book Listing 2.02

Claimants suffering from dry macular degeneration (geographic atrophy) or wet macular degeneration (choroidal neovascularization) rarely qualify through peripheral field loss. Instead, their claims turn on best-corrected visual acuity under Listing 2.02.

To meet Listing 2.02, the claimant's remaining visual acuity in the better eye after best correction must be 20/200 or less. SSA enforces several core requirements when reviewing central visual acuity:

• Best Correction: The claimant's visual acuity must be measured while wearing optimal corrective lenses. If acuity can be corrected to 20/50 with prescription spectacles, the listing is not met even if uncorrected acuity is worse than 20/200.
• Standardized Testing: SSA accepts testing performed with Snellen charts, ETDRS charts, or Landolt C charts under Section 2.00A(5) of the Blue Book.
• Better Eye Measurement: Both eyes are tested separately, and the score of the stronger eye governs the listing determination.

When macular degeneration causes scarring or atrophy that permanently reduces vision in the better eye to 20/200 or worse, the applicant qualifies for listing-level approval at Step 3.

Listing 2.04: Combined Loss of Visual Efficiency

Some claimants experience both conditions simultaneously or have visual loss that affects central acuity and peripheral field without meeting either Listing 2.02 or Listing 2.03 individually. For these complex cases, SSA provides Blue Book Listing 2.04 for loss of visual efficiency or visual impairment.

Under Listing 2.04A, SSA calculates visual efficiency by multiplying the claimant's visual acuity efficiency by their visual field efficiency. If the resulting visual efficiency percentage in the better eye is twenty percent or less after best correction, the listing is met.

Alternatively, under Listing 2.04B, SSA calculates a visual impairment score using clinical formulas outlined in Section 2.00A(7) of the Blue Book. A visual impairment value of 1.00 or greater in the better eye satisfies the listing. This combined listing ensures that claimants with multifaceted eye disease receive fair evaluation.

Objective Ophthalmic Evidence Requirements

Under 20 CFR 404.1513, visual disability must be confirmed by objective clinical findings. Subjective statements regarding blurry vision or difficulty reading do not establish eligibility. Under 20 CFR 404.1502, acceptable medical sources include licensed ophthalmologists and licensed optometrists.

A complete medical record for glaucoma or macular degeneration should include:

• Comprehensive eye examination reports showing intraocular pressures, cup-to-disc ratios, and dilated funduscopic findings.
• Formal visual acuity measurements under optimal refraction for each eye.
• Automated perimetry printouts showing reliability scores and mean deviation calculations for glaucoma claims.
• Optical coherence tomography (OCT) imaging showing retinal thickness, drusen, subretinal fluid, or geographic atrophy for macular degeneration claims.
• Fluorescein angiography reports detailing choroidal neovascular membranes in wet macular degeneration.

These objective studies substantiate the underlying disease process and confirm the severity of functional vision loss.

Visual Residual Functional Capacity (RFC) for Non-Listing Claims

Many applicants suffer from significant vision loss that does not meet the strict thresholds of Listing 2.02, 2.03, or 2.04. For example, a person with glaucoma might have a visual field diameter of 25 degrees, or a claimant with macular degeneration might have corrected acuity of 20/100.

In these situations, the claim does not end at Step 3. Under 20 CFR 404.1545, SSA must determine the claimant's Residual Functional Capacity (RFC). The visual RFC specifies how vision deficits limit workplace activities:

• Glaucoma RFC Restrictions: Peripheral field constriction creates safety hazards. Common restrictions include avoiding all workplace hazards, avoiding unprotected heights, avoiding operating dangerous machinery, and being unable to drive commercially. In addition, claimants may be unable to navigate dimly lit environments or crowded warehouses safely.
• Macular Degeneration RFC Restrictions: Central acuity loss impairs fine visual tasks. Common restrictions include inability to read standard print, inability to work on computer monitors for sustained periods, inability to perform fine assembly work, and difficulty recognizing coworker faces.

At Steps 4 and 5 of the sequential evaluation process under 20 CFR 404.1520, a vocational expert evaluates whether jobs exist in significant numbers that accommodate these non-exertional visual limitations. Under 20 CFR 404.1566, if the combined exertional and visual restrictions eliminate all competitive employment, the claim is approved.

Statutory Blindness and 2026 Earnings Limits

When a claimant meets Listing 2.02 for visual acuity of 20/200 or less, or Listing 2.03A for visual field contraction to 20 degrees or less, they are classified as statutorily blind under Section 216(i)(1) of the Social Security Act and 20 CFR 404.1581.

Statutory blindness grants substantial advantages under SSDI. In 2026, the monthly substantial gainful activity (SGA) earnings limit for statutorily blind individuals is $2,830 per month, compared to $1,690 per month in 2026 for non-blind claimants. In addition, under 20 CFR 404.130(e), statutorily blind claimants are exempt from the 20-in-40 recent-work credit test, requiring only fully insured status to qualify.

If a claimant's glaucoma or macular degeneration does not reach the statutory blindness threshold, the standard non-blind rules apply. In 2026, their gross countable monthly earnings cannot exceed $1,690 per month under 20 CFR 404.1574. In all cases, under 20 CFR 404.1509, the condition must meet the statutory duration requirement of lasting or being expected to last for a continuous period of at least twelve continuous months.

Securing Persuasive Medical Source Statements

Under 20 CFR 404.1520c, SSA evaluates medical opinions based on their supportability and consistency with the longitudinal medical record. Claimants should ask their treating ophthalmologist or optometrist to complete a detailed visual Medical Source Statement.

The treating specialist should identify specific diagnoses, summarize objective test findings, and translate visual deficits into concrete work-related restrictions. By detailing exact limitations on reading, computer use, depth perception, field of vision, and hazard avoidance, the eye specialist provides the evidentiary foundation adjudicators need to approve the claim.

Frequently Asked Questions

How does SSA evaluate glaucoma compared to macular degeneration?

SSA evaluates glaucoma primarily under Listing 2.03 based on peripheral visual field contraction, whereas macular degeneration is evaluated under Listing 2.02 based on central visual acuity loss.

Can you receive SSDI if your vision loss does not meet a Blue Book listing?

Yes. If your vision does not meet a listing, SSA assesses your visual Residual Functional Capacity to determine whether your workplace restrictions prevent you from sustaining competitive employment.

What visual tests are required to prove disability from glaucoma or macular degeneration?

SSA requires formal clinical testing from an ophthalmologist or optometrist, including best-corrected visual acuity testing, Humphrey or Goldmann visual field perimetry, and optical coherence tomography.

This article is general information about Social Security Disability Insurance eligibility, not legal advice. Program rules, earnings limits, and evaluation standards change over time, and every situation is different. Consult a qualified representative or contact the Social Security Administration directly for guidance on your specific claim.